8.51
-0.02
(-0.23%)
As of 1:18:04 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -0.27 | -0.3 | -1.22 | -0.82 |
| Low Estimate | -0.27 | -0.3 | -1.27 | -0.9 |
| High Estimate | -0.27 | -0.3 | -1.16 | -0.74 |
| Year Ago EPS | -0.25 | -0.23 | -0.99 | -1.22 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 4 | 5 |
| Avg. Estimate | -- | -- | 4.9M | 65.35M |
| Low Estimate | -- | -- | 383k | 23.54M |
| High Estimate | -- | -- | 9M | 128.3M |
| Year Ago Sales | -- | 129k | 212k | 4.9M |
| Sales Growth (year/est) | 0.00% | -100.00% | 2,210.02% | 1,234.37% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.22 | -0.22 | -0.24 | -0.28 |
| EPS Actual | -0.25 | -0.23 | -0.26 | -0.25 |
| Difference | -0.03 | -0.01 | -0.02 | 0.03 |
| Surprise % | -15.38% | -4.55% | -8.33% | 9.09% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.27 | -0.3 | -1.22 | -0.82 |
| 7 Days Ago | -0.29 | -0.32 | -1.29 | -0.88 |
| 30 Days Ago | -0.29 | -0.32 | -1.11 | -0.73 |
| 60 Days Ago | -0.29 | -0.32 | -1.11 | -0.73 |
| 90 Days Ago | -0.29 | -0.32 | -1.11 | -0.73 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 2 |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CMRX | -8.00% | -30.43% | -22.73% | 32.51% |
| S&P 500 | 6.56% | 6.52% | 9.72% | 14.29% |
Upgrades & Downgrades
| Downgrade | Jones Trading: Buy to Hold | 3/6/2025 |
| Downgrade | Jefferies: Buy to Hold | 3/5/2025 |
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 3/5/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/18/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/30/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/11/2024 |
Related Tickers
JAZZ Jazz Pharmaceuticals plc
105.90
-3.76%
TSVT 2seventy bio, Inc.
4.9450
-0.10%
PTGX Protagonist Therapeutics, Inc.
43.68
-1.71%
QURE uniQure N.V.
8.74
-2.51%
KYMR Kymera Therapeutics, Inc.
21.60
-2.13%
VLA.PA Valneva SE
2.7940
+6.89%
NUVL Nuvalent, Inc.
63.57
-3.30%
CMPX Compass Therapeutics, Inc.
1.5900
+8.90%
DRUG Bright Minds Biosciences Inc.
29.71
-7.21%
VNDA Vanda Pharmaceuticals Inc.
4.1300
-0.24%